Perinatal programming of central obesity and the metabolic syndrome: Role of glucocorticoids

Metabolic Syndrome and Related Disorders

Volumn 4, Issue 2, 2006, Pages 129-137

  Achard, Vincent ^a,b   Boullu Ciocca, Sandrine ^a,b   Desbrière, Raoul ^c   Grino, Michel ^a,b  

^a INSERM   (France)

^b AIX MARSEILLE UNIVERSITY   (France)

^c HÔPITAL NORD   (France)

Author keywords

[No Author keywords available]

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; CARBENOXOLONE; CORTICOSTERONE; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; DEXAMETHASONE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; HYDROCORTISONE; MINERALOCORTICOID RECEPTOR; OMEGA 3 FATTY ACID; PRASTERONE SULFATE;

ADIPOSE TISSUE; ARTICLE; CATCH UP GROWTH; CENTRAL NERVOUS SYSTEM; CHILD; DISEASE ASSOCIATION; EARLY DIAGNOSIS; ENDOCRINE DISEASE; ENDOCRINE FUNCTION; FEMALE; GLUCOSE INTOLERANCE; HEALTH STATUS; HORMONAL REGULATION; HUMAN; HYDROCORTISONE RELEASE; HYPERADRENOCORTICISM; HYPERTENSION; HYPOTHALAMUS HYPOPHYSIS SYSTEM; INTRAUTERINE GROWTH RETARDATION; ISCHEMIC HEART DISEASE; LOW BIRTH WEIGHT; METABOLIC DISORDER; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PERINATAL PERIOD; PERIPHERAL NERVOUS SYSTEM; PREGNANT WOMAN; PREVALENCE; PRIORITY JOURNAL; REPRODUCTIVE TOXICITY; RISK ASSESSMENT; SENSITIVITY ANALYSIS; STRESS; TREATMENT PLANNING;

EID: 33746550393     PISSN: 15404196     EISSN: None     Source Type: Journal    
DOI: 10.1089/met.2006.4.129     Document Type: Article

References (51)

1. Park YW, Zhu S, Palaniappan L, Heshka S, Carnethon MR, Heymsfield SB. The metabolic syndrome: prevalence and associated risk factors findings in the US population from the Third National Health and Nutrition Examination Survey Arch Intern Med 2003;163:427-436.
2. Bloomgarden Z. Insulin resistance in children and in the polycystic ovarian syndrome. Metab Syndr Relat Disord 2005;3:294-304.
3. Phillips DIW. Fetal programming of the neuroendocrine response to stress: links between low birth weight and the metabolic syndrome. Endocrinol Res 2004;30:819-826.
4. Forsdhal A. Are poor living conditions in childhood and adolescence an important risk factor for arteriosclerotic heart disease? Br J Prev Soc Med 1977;31:91-95.
5. Barker DJP, Osmond C. Infant mortality, childhood nutrition, and ischaemic heart disease in England and Wales. Lancet 1986;327:1077-1081.
6. Ozanne SE, Hales CN. Early programming of glucose-insulin metabolism. Trends Endocrinol Metab 2002;13:368-373.
7. Arends NJT, Boonstra VH, Duivenvoordent HJ, Hofman PL, Cutfield WS, Hokken-Koelega ACS. Reduced insulin sensitivity and the presence of cardiovascular risk factors in short prepubertal children born small for gestational age (SGA). Clin Endocrinol 2005;62:44-50.
8. Barker DJ, Osmond C, Forsen TJ, Kajantie E, Eriksson JG. Trajectories of growth among children who have coronary events as adults. N Engl J Med 2005; 353:1848-1850.
9. Ergaz Z, Avgil M, Ornoy A. Intrauterine growth restriction-etiology and consequences: what do we know about the human situation and experimental animal models? Reprod Toxicol 2005;20:301-322.
10. Seckl JR. Prenatal glucocorticoids and long-term programming. Eur J Endocrinol 2004;151:U49-U62.
11. Hales CN, Barker DJP. Type 2 (non-insulin dependent) diabetes mellitus: the thrifty phenotype hypothesis. Diabetologia 1992;35:595-601.
12. Nyirenda MJ, Lindsay RS, Kenyon CJ, Burchell A, Seckl JR. Glucocorticoid exposure in late gestation permanently programs rat hepatic phosphoenolpyruvate carboxykinase and glucocorticoid receptor expression and causes glucose intolerance in adult offspring. J Clin Invest 1998;101:2174-2181.
13. Cleasby ME, Kelly PAT, Walker BR, Seckl JR. Programming of rat muscle and fat metabolism by in utero overexposure to glucocorticoids. Endocrinology 2003;144:999-1007.
14. Theogaraj E, John CD, Christian HC, Morris JF, Smith SF, Buckingham JC. Perinatal glucocorticoid treatment produces molecular, functional, and morphological changes in the anterior pituitary gland of the adult male rat. Endocrinology 2005;146:4804-4813.
15. Welberg LA, Seckl JR, Holmes MC. Inhibition of 11β-hydroxysteroid dehydrogenase, the foeto-placental barrier to maternal glucocorticoids, permanently programs amygdala GR mRNA expression and anxiety-like behavior in the offspring. Eur J Neurosci 2000;12:1047-1054.
16. Nilsson C, Larsson BM, Jennische E, Eriksson E, Björntorp P, York DA, Holmäng A. Maternal endotoxemia results in obesity and insulin resistance in adult male offspring. Endocrinology 2001;142: 2622-2630.
17. Gnanalingham MG, Mostyn A, Symonds ME, Stephenson T. Ontogeny and nutritional programming of adiposity in sheep: potential role of glucocorticoid action and uncoupling protein 2. Am J Physiol Regul Integr Comp Physiol 2005;289: R1407-R1415.
18. Gesina E, Tronche F, Herrera P, Duchene B, Tales W, Czernichow P, Breant B. Dissecting the role of glucocorticoids on pancreas development. Diabetes 2004;53:2322-2329.
19. Matthews SG. Early programming of the hypothalamo-pituitary-adrenal axis. Trends Endocrinol Metab 2002;13:373-380.
20. Boullu-Ciocca S, Dutour A, Guillaume V, Achard V, Oliver C, Grino M. Postnatal diet-induced obesity in rats up regulates systemic and adipose tissue glucocorticoid metabolism during development and in adulthood: its relationship with the metabolic syndrome. Diabetes 2005;54:197-203.
21. Weaver ICG, Cervoni N, Champagne FA, D'Alessio AC, Sharma S, Seckl JR, Dymov S, Szyf M, Meaney MJ. Epigenetic programming by maternal behavior. Nat Neurosci 2004;7:847-854.
22. Wyrwoll CS, Mark PJ, Mori TA, Puddey IB, Waddell BJ. Prevention of programmed hyperleptinemia and hypertension by postnatal dietary omega-3 fatty acids. Endocrinology 2006;147:599-606.
23. Hermanowski-Vosatka A, Balkovec JM, Cheng K, Chen HY, Hernandez M, Koo GC, Le Grand CB, Li Z, Metzger JM, Mundt SS, Noonan H, Nunes CN, Olson SH, Pikounis B, Ren N, Robertson N, Schaeffer JM, Shah K, Springer MS, Strack AM, Strowski M, Wu K, Wu T, Xiao J, Zhang BB, Wright SD, Thieringer R. 11β-HSD1 inhibition ameliorates metabolic syndrome and prevents progression of atherosclerosis in mice. J Exp Med 2005;202:517-527.
24. Shams M, Kilby MD, Somerset DA, Howie AJ, Gupta A, Wood PJ, Afnan M, Stewart PM. 11β-Hydroxy-steroid dehydrogenase type 2 in human pregnancy and reduced expression in intrauterine growth restriction. Hum Reprod 1998;13:799-804.
25. Hahn T, Barth S, Graf R, Engelmann M, Beslagic D, Reul JMHM, Holsboer F, Dohr G, Desoye G. Placental glucose transporter expression is regulated by glucocorticoids. J Clin Endocrinol Metab 1999;84: 1145-1152.
26. Parker CR Jr, Buchina ES, Barefoot TK. Abnormal adrenal steroidogenesis in growth-retarted newborns infants. Pediatr Res 1994;35:633-636.
27. Radetti G, Renzullo L, Gottardi E, D'Addato G, Messner H. Altered thyroid and adrenal function in children born at term and preterm, small for gestational age. J Clin Endocrinol Metab 2004;89:6320-6324.
28. Economides DL, Nicolaides KH, Campbell S. Metabolic and endocrine findings in appropriate and small for gestational age fetuses. J Perinat Med 1991; 19:97-105.
29. Doerr HG, Versmold HT, Bidlingmaier F, Sippell WG. Adrenocortical steroids in small-for-gestational-age infants during the early neonatal period. Pediatr Res 1989;25:115-118.
30. Dahlgren J, Boguszewski M, Rosberg S, Albertsson-Wikland K. Adrenal steroid hormones in short children born small for gestational age. Clin Endocrinol 1998;49:353-361.
31. Clarck PM, Hindmarsch PC, Shiell AW, Law CM, Honour JW, Barker DJP. Size at birth and adrenocortical function in chilhood. Clin Endocrinol 1996;45: 721-726.
32. Cianfarani S, Geremia C, Scott CD, Germani D. Growth, IGF system, and cortisol in children with intrauterine growth retardation: is catch-up growth affected by reprogramming of the hypothalamic-pituitary-adrenal axis? Pediatr Res 2001;51:94-99.
33. Tenhola S, Turpeinen U, Halonen P, Hämäläinen E, Voutilainen R. Association of serum lipid concentrations, insulin resistance index and catch-up growth with serum cortisol/cortisone ration by liquid chromatography tandem mass spectrometry in children born small for gestational age. Pediatr Res 1995;58: 467-471.
34. Tenhola S, Martikainen A, Rahiala E, Parviainen M, Halonen P, Voutilainen R. Increased adrenocortical and adrenomedullary hormonal activity in 12-year-old children born small for gestational age. J Pediatr 2002;141:477-482.
35. Houang M, Morineau G, le Bouc Y, Fiet J, Gourmelen M. The cortisol-cortisone shuttle in children born with intrauterine growth retardation. Pediatr Res 1999;46:189-193.
36. Jaquet D, Deghmoun S, Chevenne D, Collin D, Czernichow P, Lévy-Marchal C. Dynamic changes in adiposity from fetal to postnatal life is involved in the metabolic syndrome associated with reduced fetal growth. Diabetologia 2005;48:849-855.
37. Ong KKL, Ahmed ML, Emmett PM, Preece MA, Dunger DB, and the Avon Longitudinal Study of Pregnancy and Childhood Study Team. Association between postnatal catch-up growth and obesity in childhood: prospective cohort study. Br Med J 2000; 320:967-971.
38. Petersen S, Gotfredsen A, Knudsen FU. Lean body mass in small for gestational age and appropriate for gestational age infants. J Pediatr 1988;113:886-889.
39. Hediger ML, Overpeck MD, Kuczmarski RJ, McGlynn A, Maurer KR, Davis WW. Muscularity and fatness of infants and young children born small- or large-for-gestational-age. Pediatrics 1998;102:E60.
40. Mericq V, Ong KK, Bazaes R, Peña V, Avila A, Salazar T, Soto N, Iñiguez G, Dunger DB. Longitudinal changes in insulin sensitivity and secretion from birth to age three years in small- and appropriate-for-gestational-age children. Diabetologia 2005;48: 2609-2614.
41. Labayen I, Moreno LA, Blay MG, Blay VA, Mesana MI, González-Gross M, Bueno G, Sarria A, Bueno M. Early programming of body composition and fat distribution in adolescents. J Nutr 2006;136:147-152.
42. Kensara OA, Wootton SA, Phillips DI, Patel M, Jackson AA, Elia M, and the Hertfordshire Study Group. Fetal programming of body composition: relation between birth weight and body composition measured with dual-energy x-ray absorptiometry and anthropometric methods in older Englishmen. Am J Clin Nutr 2005;82:980-987.
43. Dimitriou T, Maser-Gluth C, Remer T. Adrenocortical activity in healthy children is associated with fat mass. Am J Clin Nutr 2003;77:731-736.
44. Kajantie E, Phillips DIW, Andersson S, Barker DJP, Dunkel L, Forsén T, Osmond C, Tuominen J, Wood PJ, Eriksson J. Size at birth, gestational age and cortisol secretion in adult life: foetal programming of both hyper- and hypocortisolism? Clin Endocrinol 2002; 57:635-641.
45. Kajantie E, Eriksson J, Osmond C, Woods PJ, Forsén T, Barker DJP, Phillips DIW. Size at birth, the metabolic syndrome and 24-h salivary cortisol profile. Clin Endocrinol 2004;60:201-207.
46. Nilsson PM, Nilsson J-Å, Östergren P-O, Rasmussen F. Fetal growth predicts stress susceptibility independent of parental education in 161 991 adolescent Swedish male conscripts. J Epidemiol Commun Health 2004;58:571-573.
47. Wüst S, Entringer S, Federenko IS, Schlotz W, Hellhammer DH. Birth weight is associated with salivary cortisol responses to psychosocial stress in adult life. Psychoneuroendocrinology 2005;30:591-598.
48. Reynolds RC, Walker BR, Syddall HE, Andrew R, Wood PJ, Whorwood CB, Phillips DIW. Altered control of cortisol secretion in adult men with low birth weight and cardiovascular risk factor. J Clin Endocrinol Metab 2001;86:245-250.
49. Levitt NS, Lambert EV, Woods D, Hales N, Andrew R, Seckl JR. Impaired glucose tolerance and elevated blood pressure in low birth weight, nonobese, young South African adults: early programming of cortisol axis. J Clin Endocrinol Metab 2000;85:4611-4618.
50. Ward AM, Syddall HE, Wood PJ, Denninson EM, Phillips DI. Central hypothalamic-pituitary-adrenal activity and the metabolic syndrome: studies using the corticotrophin-releasing hormone test. Metabolism 2004;53:720-726.
51. 1-24 stimulation. Eur J Endocrinol 2003; 149:569-575.